J. McGuire, M. Saifeddine, C. Triggle
Jun 1, 2004
Citations
5
Influential Citations
117
Citations
Quality indicators
Journal
Journal of Pharmacology and Experimental Therapeutics
Abstract
A peptide corresponding to a proteinase-activated receptor 2 (PAR2)-activating peptide with an N-terminal furoyl group modification, 2-furoyl-LIGRLO-NH2, was assessed for PAR2-dependent and -independent biological activities. 2-Furoyl-LIGRLO-NH2 was equally effective to and 10 to 25 times more potent than SLIGRLNH2 for increasing intracellular calcium in cultured human and rat PAR2-expressing cells, respectively. In bioassays of tissue PAR2 activity, measured as arterial vasodilation and hyperpolarization, 2-furoyl-LIGRLO-NH2 was 10 to 300 times more potent than SLIGRL-NH2. Unlike trans-cinnamoyl-LIGRLO-NH2, 2-furoyl-LI-GRLO-NH2 did not cause a prominent non-PAR2-mediated contraction of murine femoral arteries. In conclusion, 2-furoyl-LI-GRLO-NH2 represents the most potent and selective activator of PAR2 in biological systems described to date.